ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study (2021)
Debureaux, Pierre-Edouard; Kulasekararaj, Austin G.; Cacace, Fabiana; Silva, Bruno Garcia Peixoto Pires da; Calado, Rodrigo Tocantins ; Barone, Federica; Fontbrune, Flore Sicre de; Prata, Pedro Henrique de Lima ; Soret, Juliette; Sica, Michela; Notaro, Rosario; Scheinberg, Phillip ; Mallikarjuna, Vasundhara; Gandhi, Shreyans; Large, Joanna; Risitano, Antonio M.; Latour, Régis Peffault de; Frieri, Camilla
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, HEMOGLOBINAS, ESTUDOS MULTICÊNTRICOS, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEBUREAUX, Pierre-Edouard et al. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41409-021-01372-0. Acesso em: 02 nov. 2025. , 2021
APA
Debureaux, P. -E., Kulasekararaj, A. G., Cacace, F., Silva, B. G. P. P. da, Calado, R. T., Barone, F., et al. (2021). Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study. Bone Marrow Transplantation. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1038/s41409-021-01372-0
NLM
Debureaux P-E, Kulasekararaj AG, Cacace F, Silva BGPP da, Calado RT, Barone F, Fontbrune FS de, Prata PH de L, Soret J, Sica M, Notaro R, Scheinberg P, Mallikarjuna V, Gandhi S, Large J, Risitano AM, Latour RP de, Frieri C. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study [Internet]. Bone Marrow Transplantation. 2021 ; 56( 10): 2600-2602.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1038/s41409-021-01372-0
Vancouver
Debureaux P-E, Kulasekararaj AG, Cacace F, Silva BGPP da, Calado RT, Barone F, Fontbrune FS de, Prata PH de L, Soret J, Sica M, Notaro R, Scheinberg P, Mallikarjuna V, Gandhi S, Large J, Risitano AM, Latour RP de, Frieri C. Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria [Carta]: a multicenter real-life study [Internet]. Bone Marrow Transplantation. 2021 ; 56( 10): 2600-2602.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1038/s41409-021-01372-0
Artigo de periodico
Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT (2019)
Risitano, Antonio M.; Marotta, Serena; Ricci, Patrizia; Marano, Luana; Frieri, Camilla; Cacace, Fabiana; Sica, Michela; Kulasekararaj, Austin G.; Calado, Rodrigo Tocantins ; Scheinberg, Phillip; Notaro, Rosario; Latour, Régis Peffault de
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: HEMOGLOBINAS, HEMATOLOGIA, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RISITANO, Antonio M. et al. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.01157. Acesso em: 02 nov. 2025.
APA
Risitano, A. M., Marotta, S., Ricci, P., Marano, L., Frieri, C., Cacace, F., et al. (2019). Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.01157
NLM
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2025 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2019.01157
Vancouver
Risitano AM, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, Sica M, Kulasekararaj AG, Calado RT, Scheinberg P, Notaro R, Latour RP de. Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT [Internet]. Frontiers in Immunology. 2019 ; 10[citado 2025 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2019.01157
Artigo de periodico
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms (2018)
Marsh, Judith C. W. ; Gutierrez-Rodrigues, Fernanda ; Cooper, James; Jiang, Jie; Gandhi, Shreyans; Kajigaya, Sachiko; Feng, Xingmin; Ibanez, Maria del Pilar F.; Donaires, Flávia Sacilotto ; Silva, João Paulo Lopes da ; Li, Zejuan; Das, Soma; Ibanez, Maria; Smith, Alexander E.; Lea, Nicholas; Best, Steven; Ireland, Robin; Kulasekararaj, Austin G.; McLornan, Donal P.; Pagliuca, Anthony ; Callebaut, Isabelle ; Young, Neal S.; Calado, Rodrigo Tocantins ; Townsley, Danielle M.; Mufti, Ghulam J.
Source: Blood Advances. Unidade: FMRP
Subjects: NEOPLASIAS, MEDULA ÓSSEA, TELÔMERO, DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARSH, Judith C. W. et al. Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms. Blood Advances, v. 2, n. 1, p. 36-48, 2018Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017008110. Acesso em: 02 nov. 2025.
APA
Marsh, J. C. W., Gutierrez-Rodrigues, F., Cooper, J., Jiang, J., Gandhi, S., Kajigaya, S., et al. (2018). Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms. Blood Advances, 2( 1), 36-48. doi:10.1182/bloodadvances.2017008110
NLM
Marsh JCW, Gutierrez-Rodrigues F, Cooper J, Jiang J, Gandhi S, Kajigaya S, Feng X, Ibanez M del PF, Donaires FS, Silva JPL da, Li Z, Das S, Ibanez M, Smith AE, Lea N, Best S, Ireland R, Kulasekararaj AG, McLornan DP, Pagliuca A, Callebaut I, Young NS, Calado RT, Townsley DM, Mufti GJ. Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms [Internet]. Blood Advances. 2018 ; 2( 1): 36-48.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1182/bloodadvances.2017008110
Vancouver
Marsh JCW, Gutierrez-Rodrigues F, Cooper J, Jiang J, Gandhi S, Kajigaya S, Feng X, Ibanez M del PF, Donaires FS, Silva JPL da, Li Z, Das S, Ibanez M, Smith AE, Lea N, Best S, Ireland R, Kulasekararaj AG, McLornan DP, Pagliuca A, Callebaut I, Young NS, Calado RT, Townsley DM, Mufti GJ. Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms [Internet]. Blood Advances. 2018 ; 2( 1): 36-48.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1182/bloodadvances.2017008110

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration